News

New discovery in the brewing process of lambic

Scientists from the VUB research group Industrial Microbiology and Food Biotechnology (IMDO) have made an important new discovery about the brewing process of lambic, the basic brew for the production of…

UZ Brussel uses immunotherapy to tackle aggressive brain tumor

For the first time worldwide, UZ Brussel injected immunotherapy locally in the brains of patients who suffer from glioblastoma. Never before had a treatment in a clinical study shown that the survival of…

Knowledge for growth: Call for abstracts 2019

The call for abstracts for the 15th edition of knowledge for growth on 9 May 2019 in Ghent is now open. Deadline for submissions: 08/02/2019. More info.

VUB spin-off 24SEA exists 2 years

24SEA was founded two years ago by engineers Gert De Sitter and Christof Devriendt at VUB. The startup helps to extend the life of wind turbines, by measuring and interpreting data with its sensors from…

New UGent/VUB spin-off Gulliver Biomed brings llama antibodies to research community

Gulliver Biomed will develop customer-oriented antibodies in lamas that can then be used as a tool in fundamental research, but also for evaluation in (pre-) clinical studies as potential candidates…

Biobest and Bee Vectoring Technologies close license agreement

The Canadian Bee Vectoring Technologies International Inc. (BVT), a leading developer of solutions for sustainable agriculture, and the Belgian Biobest Group NV, a world player in pollination and biological…

Catalisti Calls for Partners 2018

1. RFP ‘Plastic to Precious Chemicals(P2PC)'  A conventional processing train for upgrading pyrolysis oil to attractive chemicals consists of different steps such as cracking step, separation steps…

VUB-app makes care easier and less expensive for chronically ill

Professor An Jacobs and researcher Janneke Kuiper (SMIT - imec) are developing an app called ProACT, that allows people with multiple chronic conditions to monitor their medical condition at home on a tablet. …

Call Innoviris Launch – Brussels Spin-off 2019

Do you work in a research organization and would you like to develop the results from your scientific research by creating a new business in the Brussels-Capital Region? Submit a funding application…

UZ Brussel research offers a new perspective for melanoma patients

For the first time ever a melanoma patient was treated at the UZ Brussel with an 'intelligent anti-cancer virus' in combination with dendritic cells (the body's own cells that attack and disarm cancer cells).